Medical devices, healthcare technology and the business of care
FDA RECALL RECORD · Z-0875-2026

Senographe Pristina, Pristina Serena, and Pristina Serena 3D. for screening and diagnostic mammography Recall

Senographe Pristina, Pristina Serena, and Pristina Serena 3D. for screening and diagnostic mammography

FDA recall Class II

Ongoing

FDA lists this Class II recall for Senographe Pristina, Pristina Serena, and Pristina Serena 3D. for screening and diagnostic mammography. Review the affected identifiers, reported reason and manufacturer instructions below.

Recall at a glance

Recall number
Z-0875-2026
Recall classification
Class II
Enforcement status
Ongoing
Initiation date
Oct 24, 2025
FDA report date
Dec 17, 2025
Quantity in commerce
1,818 (1,580 US; 238 OUS)
Distribution
See key details
FDA cause
Radiation Control for Health and Safety Act

What is being recalled?

Senographe Pristina, Pristina Serena, and Pristina Serena 3D. for screening and diagnostic mammography

Affected model & UDI checker

Search the exact identifiers published for Z-0875-2026.

The lookup covers structured identifiers listed on this page. A full UDI may also contain lot or serial information; a GTIN match alone does not check those conditions.

Affected products

Model / catalog numberProductLot scope reportedUDI / GTIN
Not specifiedSenographe Pristina, Pristina Serena, and Pristina Serena 3D. for screening and diagnostic mammographyCheck source notice00840682118460
Not specifiedSenographe Pristina, Pristina Serena, and Pristina Serena 3D. for screening and diagnostic mammographyCheck source notice00840682142052
Not specifiedSenographe Pristina, Pristina Serena, and Pristina Serena 3D. for screening and diagnostic mammographyCheck source notice00840682145879
Not specifiedSenographe Pristina, Pristina Serena, and Pristina Serena 3D. for screening and diagnostic mammographyCheck source notice00195278022745
Not specifiedSenographe Pristina, Pristina Serena, and Pristina Serena 3D. for screening and diagnostic mammographyCheck source notice00195278276971
Not specifiedSenographe Pristina, Pristina Serena, and Pristina Serena 3D. for screening and diagnostic mammographyCheck source notice00195278661999
Not specifiedSenographe Pristina, Pristina Serena, and Pristina Serena 3D. for screening and diagnostic mammographyCheck source notice00195278665379
Not specifiedSenographe Pristina, Pristina Serena, and Pristina Serena 3D. for screening and diagnostic mammographyCheck source notice00195278914026
FDA code information

GTINs: 00840682118460, 00840682142052, 00840682145879, 00195278022745, 00195278276971, 00195278661999, 00195278665379, 00195278914026

View the original FDA recall notice

Why was this product recalled?

Some Senographe Pristina systems either have a missing or an incorrect X-Ray Warning label, which is a nonconformance to FDA Regulation 21 CFR ¿1020.30(j).

What actions did GE Medical Systems, LLC take?

GE Healthcare notified sent customers notification letter dated October 24, 2025 and instructed in the letter, the customer will inspect and identify systems that have a missing or incorrect label.

Read the manufacturer action recorded by FDA

Recall timeline

  1. Recall initiated by firm

  2. FDA notice posted

  3. FDA classification recorded

  4. FDA enforcement report date

Related FDA submissions

No submission number with an exact verified relationship is linked in the retrieved recall notice.

FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.

Source and update history

  1. FDA enforcement data

    First stored snapshot of this source.

  2. FDA device-recall notice

    First stored snapshot of this source.

The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.

Our data sources and methodology